Wellington Management Group LLP Vincerx Pharma, Inc. Transaction History

Wellington Management Group LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.0 - $0.0 $0 - $0	-394,246 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$0.0 - $0.0 $0 - $0	61,329 Added 18.42%	394,246 $4.02 Million
Q3 2021 Nov 15, 2021	SELL	$0.0 - $0.0 $0 - $0	-585,056 Reduced 63.73%	332,917 $5.38 Million
Q2 2021 Aug 16, 2021	SELL	$0.0 - $27.0 $0 - $422,982	-15,666 Reduced 1.68%	917,973 $11.9 Million
Q1 2021 May 17, 2021	BUY	$22.6 - $31.0 $21.1 Million - $28.9 Million	933,639 New	933,639 $18 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.